An HPLC–MS/MS method for simultaneous determination of the active metabolites of febuxostat (67M-1, 67M-2 and 67M-4) in human plasma
- 6 September 2014
- journal article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 970, 24-30
- https://doi.org/10.1016/j.jchromb.2014.08.038
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A sensitive LC‐MS/MS method for the quantification of febuxostat in human plasma and its pharmacokinetic applicationBiomedical Chromatography, 2013
- Bioequivalance and pharmacokinetic study of febuxostat in human plasma by using LC-MS/MS with liquid liquid extraction methodSpringerPlus, 2013
- Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of febuxostat in human plasmaBiomedical Chromatography, 2012
- Metabolism and Excretion of [14C] Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase, in Healthy Male SubjectsThe Journal of Clinical Pharmacology, 2011
- In vitrodrug–drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibitionXenobiotica, 2008
- The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine OxidaseThe Journal of Clinical Pharmacology, 2006